AMERICAN BATTERY TECHNOLOGY Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERICAN BATTERY TECHNOLOGY Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2019 | $0 | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | $0 | Dec 27, 2019 |
| FY2016 | Sep 30, 2016 | $0 | Dec 30, 2016 |
| FY2016 | Sep 30, 2015 | $0 | Dec 30, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.29M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $343.5K | Sep 18, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($10.57M) | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | ($2.96M) | Sep 18, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($46.76M) | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | ($52.50M) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | ($21.34M) | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | ($33.54M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($41.76M) | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | ($13.32M) | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | ($12.63M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2018 | ($6.05M) | Dec 31, 2018 |
| FY2018 | Sep 30, 2017 | ($2.69M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($28.36M) | Jan 18, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($42.02M) | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | ($47.77M) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | ($22.43M) | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | ($33.74M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($37.72M) | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | ($4.39M) | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | ($10.49M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2018 | ($5.59M) | Dec 31, 2018 |
| FY2018 | Sep 30, 2017 | ($2.20M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($2.40M) | Jan 18, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.47M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $14.33M | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | $7.57M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $963.4K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $857.6K | Sep 12, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($28.92M) | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | ($16.74M) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | ($13.37M) | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | ($10.18M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($7.76M) | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | ($3.02M) | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | ($3.43M) | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | ($993.4K) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($484.9K) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($199.4K) | Jan 18, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $6.76M | Sep 28, 2023 |
| FY2023 | Jun 30, 2022 | $12.87M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $5.44M | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | $3.9K | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | $0 | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | $10.2K | Dec 27, 2019 |
| FY2017 | Sep 30, 2016 | $0 | Jan 18, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $84.46M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $77.68M | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | $74.66M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $52.86M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $21.26M | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | $1.16M | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | $92.7K | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | $308.8K | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $61.6K | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | $90.0K | Jan 18, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.86M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $16.21M | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | $13.79M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $3.23M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.82M | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | $6.10M | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | $4.88M | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | $2.74M | Dec 27, 2019 |
| FY2017 | Sep 30, 2016 | $634.0K | Jan 18, 2018 |
| FY2016 | Sep 30, 2015 | $101.7K | Dec 30, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $70.60M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $61.47M | Sep 18, 2025 |
| FY2025 | Jun 30, 2023 | $60.87M | Sep 18, 2025 |
| FY2024 | Jun 30, 2022 | $49.63M | Sep 23, 2024 |
| FY2023 | Jun 30, 2021 | $19.44M | Sep 28, 2023 |
| FY2022 | Jun 30, 2020 | ($4.94M) | Sep 12, 2022 |
| FY2021 | Sep 30, 2019 | ($4.79M) | Oct 13, 2021 |
| FY2019 | Sep 30, 2018 | ($2.43M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($1.27M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($544.0K) | Jan 18, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($260.09M) | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | ($213.33M) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | ($160.83M) | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | ($138.64M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($105.07M) | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | ($63.21M) | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | ($49.89M) | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | ($37.27M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($31.22M) | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | ($28.53M) | Jan 18, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.47M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | $7.00M | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | $2.32M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $28.99M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $12.84M | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | $829.9K | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | $7.4K | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | $122.8K | Dec 27, 2019 |
| FY2019 | Sep 30, 2017 | $9.1K | Dec 27, 2019 |
| FY2018 | Sep 30, 2016 | $90.0K | Dec 31, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2024 | $2.10M | Sep 18, 2025 |
| FY2024 | Jun 30, 2024 | $7.08M | Sep 23, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 12, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 97.40M | Sep 18, 2025 |
| FY2025 | Jun 30, 2024 | 64.06M | Sep 18, 2025 |
| FY2024 | Jun 30, 2023 | 45.89M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 42.94M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 573.27M | Sep 12, 2022 |
| FY2021 | Jun 30, 2020 | 365.19M | Oct 13, 2021 |
| FY2019 | Sep 30, 2019 | 132.68M | Dec 27, 2019 |
| FY2019 | Sep 30, 2018 | 93.33M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | 58.50M | Dec 31, 2018 |
| FY2017 | Sep 30, 2016 | 57.14M | Jan 18, 2018 |